3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
21
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
7
Skin Neoplasms
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Colorectal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Uveal Melanoma
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pleural Effusion, Malignant
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Interventions
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
3
pembrolizumab
2
cabozantinib
2
aldesleukin
2
Specimen Handling
2
CTLA-4 Antigen
2
Adoptive Transfer
2
niraparib
1
lenvatinib
1
entinostat
1
enfortumab vedotin
1
dostarlimab
1
cemiplimab
1
bintrafusp alfa protein, human
1
avelumab
1
Psychiatric Nursing
1
Platinum
1
Physical Therapy Modalities
1
Palliative Care
1
Paclitaxel
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Cisplatin
1
CP protocol
1
Biopsy
1
BAY 1895344
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Penile Neoplasms
×
Interleukin-2
×
1 year
×
Clear all
No trials found.